MBP 3.23% 3.0¢ metabolic pharmaceuticals limited

sinking again, page-4

  1. 549 Posts.
    lightbulb Created with Sketch. 9
    Once the part-timers disappear, I can't see much holding it at these levels. Sure the pain drug looks promising, but so did the fat pill. MBP's reputation must have been shattered in the biotech world today. Not because the fat pill was a flop, but because of their misleading presentations in both the 2004 and 2007 results. If it is a flop, just say so, rather than trying to manipulate the facts.
 
watchlist Created with Sketch. Add MBP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.